These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2936037)

  • 1. Active immunization against hepatitis B: immunogenicity study in homosexual men.
    Bienzle U; Rohr A; Thomssen R; Ritter K; Uy A; Kalden JR; Kalies J; Guggenmoos-Holzmann I
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Nov; 260(3):403-10. PubMed ID: 2936037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of anti-HBc in anti-HBs positive individuals: implications for selecting vaccine candidates.
    Hanson M; Polesky HF
    Am J Clin Pathol; 1984 Dec; 82(6):716-9. PubMed ID: 6239539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of immune potentiation by complexing HBsAg in a heat-inactivated hepatitis B vaccine with antibody in hepatitis B immunoglobulin.
    Lelie PN; van Amelsfoort PJ; Martine de Groot CS; Bakker E; Schaasberg W; Niessen JC; Reesink HW
    Hepatology; 1989 Jul; 10(1):36-8. PubMed ID: 2737602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen.
    McMahon BJ; Parkinson AJ; Helminiak C; Wainwright RB; Bulkow L; Kellerman-Douglas A; Schoenberg S; Ritter D
    Gastroenterology; 1992 Aug; 103(2):590-4. PubMed ID: 1386048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against hepatitis B on the Ivory Coast: study of the anti-HBs response in healthy adult subjects carrying only anti-HBc antibodies before vaccination].
    Ouattara SA; Meite M; Aron Y
    Bull Soc Pathol Exot Filiales; 1986; 79(1):27-38. PubMed ID: 3698152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous passive and active immunization against hepatitis B: noninterference of hepatitis B immune globulin with the anti-HBs response to reduced doses of heat-inactivated hepatitis B vaccine.
    Lelie PN; Reesink HW; Grijm R; de Jong-van Manen ST; Reerink-Brongers EE
    Hepatology; 1986; 6(5):971-5. PubMed ID: 3758947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].
    Palmović D; Vitas B; Doko A; Belavić Z; Racki L
    Lijec Vjesn; 1989 Nov; 111(11):400-4. PubMed ID: 2534601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzyme-linked immunosorbent assay (ELISA) for the detection of IgG and IgM anti-idiotypes directed against anti-HBs molecules.
    Irshad M; Gandhi BM; Acharya SK; Joshi YK; Tandon BN
    J Immunol Methods; 1987 Feb; 96(2):211-7. PubMed ID: 2949020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs.
    Lok AS; Lai CL; Wu PC
    Hepatology; 1988; 8(4):766-70. PubMed ID: 2968945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.